-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HfEPFO0c/7kETlp8JKwPqqBRhY2+V1yxN9u140UQY35Zvop0n4iog/AUnsXpKPEB WNp/gyMj4uwRBj/ajC7DoA== 0001005150-04-000078.txt : 20040121 0001005150-04-000078.hdr.sgml : 20040121 20040121143956 ACCESSION NUMBER: 0001005150-04-000078 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040116 ITEM INFORMATION: Other events FILED AS OF DATE: 20040121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 04534829 BUSINESS ADDRESS: STREET 1: SUNY PARK SCIENCE III STREET 2: SUITE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 BUSINESS PHONE: 6077772775 MAIL ADDRESS: STREET 1: SUNYPARK SCIENCE III STREET 2: STE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ------------------------------------ Date of report (Date of earliest event reported): January 16, 2004 ---------------- BIOLIFE SOLUTIONS, INC. ------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Delaware 0-18170 94-3076866 - ---------------------------- -------------------- -------------------- (State or Other Jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Suite 144 - Science III, SUNY Park, Binghamton, NY 13902 -------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (607) 777-4415 ------------- N/A -------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report.) ITEM 5. Other Events and Required FD Disclosure - ------- --------------------------------------- BioLife Solutions Inc. announced today that it has secured, to date, $1,381,250 through the sale, in a private placement to investors, of Units consisting of Series G Convertible Preferred Stock and warrants. Each Unit sold for $25,000 and consisted of one (1) share of Series G Convertible Preferred Stock, convertible into 312,500 shares of the Company's common stock, and a warrant to purchase 312,500 shares of the Company's common stock, on or before October 31, 2013, at $0.08 per share. The proceeds of the offering will be used for working capital purposes, including the payment of payables. Signatures: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOLIFE SOLUTIONS, INC. By: /s/ John G. Baust ----------------------- John G. Baust Chief Executive Officer Date: January 21, 2004 -----END PRIVACY-ENHANCED MESSAGE-----